about
Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cellsExploring the CK2 Paradox: Restless, Dangerous, Dispensable.Protein kinase CK2 potentiates translation efficiency by phosphorylating eIF3j at Ser127.Aberrant signalling by protein kinase CK2 in imatinib-resistant chronic myeloid leukaemia cells: biochemical evidence and therapeutic perspectives.CK2 is a key regulator of SLC4A2-mediated Cl-/HCO3- exchange in human airway epithelia.Generation and quantitative proteomics analysis of CK2α/α'(-/-) cells.Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies.CK2 modulates adipocyte insulin-signaling and is up-regulated in human obesity.Re-evaluation of protein kinase CK2 pleiotropy: new insights provided by a phosphoproteomics analysis of CK2 knockout cells.Dependence of HSP27 cellular level on protein kinase CK2 discloses novel therapeutic strategiesSynthesis and evaluation of platelet aggregation inhibitory activity of some 3-phenyl-pyrroloquinazolinonesRegulation of serotonin transport in human platelets by tyrosine kinase SykThe protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cellsA Journey through the Cytoskeleton with Protein Kinase CK2Protein Kinase CK2 Subunits Differentially Perturb the Adhesion and Migration of GN11 Cells: A Model of Immature Migrating NeuronsRole of protein kinase CK2 in antitumor drug resistanceA proteomics analysis of CK2β(-/-) C2C12 cells provides novel insights into the biological functions of the non-catalytic β subunit
P50
Q28485087-405898BF-A8C1-4CFC-94BF-3E3EAE63B0B2Q39100833-44E6FF99-77E6-4B9E-85CC-42AB9CEE59DEQ41050533-60A1A1A9-291D-483F-8EBC-785F24E3BF20Q41134308-B8993E24-D1E8-472F-8C02-6749FF0A6EB1Q41368424-EDA7F4B2-A2F4-4D57-819B-245CE033382FQ41835528-CB965221-96EF-48D5-9920-A5F9B89A21CCQ42412981-4DBB8A4D-2D86-4BC8-9A00-E7F880FD3691Q47133076-9E7832C8-FCB0-4A77-BBD6-573AFBD7B26CQ47422811-9FB640E0-392E-4C45-BCB8-4F2EF264CD68Q57071671-92993C89-7929-4007-9520-07720B701693Q83211372-5DACFA57-3311-46A5-83AC-11807AF247BAQ83421906-2F5292C1-1024-4CDE-9251-41A41545ACDDQ90883692-766D3F00-EA33-4F48-92CD-D2D62753AF39Q91119103-FF200700-92E9-43D5-B2AF-7E1826DCB048Q91514277-F6B1E675-4FC5-4F3C-AEA6-80A01DA457F3Q91660422-6E6CEDCF-E67F-4461-9671-2A7F2D36221AQ92134448-847AD837-AA61-4942-9DF6-170F73FC2994
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-9540-8145
@en
name
Christian Borgo
@ast
Christian Borgo
@en
Christian Borgo
@es
Christian Borgo
@nl
type
label
Christian Borgo
@ast
Christian Borgo
@en
Christian Borgo
@es
Christian Borgo
@nl
prefLabel
Christian Borgo
@ast
Christian Borgo
@en
Christian Borgo
@es
Christian Borgo
@nl
P106
P1153
42360898400
P21
P31
P496
0000-0001-9540-8145